Literature DB >> 7702051

Preserved antioxidative defense of lipoproteins in renal failure and during hemodialysis.

T Schulz1, H Schiffl, R Scheithe, N Hrboticky, R Lorenz.   

Abstract

Contact to artificial surfaces during hemodialysis activates leukocytes, which then form oxidized arachidonic acid products and free radicals. This might promote the oxidative modification of low-density lipoproteins (LDL) that play a key role in the initiation of atherosclerosis. Thus, leukocyte activation could specifically contribute to the high mortality from atherosclerotic complications on long-term hemodialysis. Therefore monitored LDL and high-density lipoprotein (HDL) resistance to copper-stimulated oxidation in patients with end-stage renal disease on maintenance hemodialysis with cellulose acetate or polysulfone membranes (n = 12), in patients with chronic renal failure (n = 13) and in healthy controls (n = 12). Six of the dialysis patients were restudied during a single cuprophane dialysis. Circulating leukocytes were reversibly reduced early in hemodialysis with cellulose acetate (minimum, 83.6% +/- 7.4% of baseline values at 30 minutes after dialysis start), polysulfone (minimum, 80.4% +/- 10.5% at 15 minutes; P < 0.05) and cuprophane (minimum, 24.5% +/- 8.5% at 60 minutes; P < 0.0001). Despite the leukocyte activation, LDL oxidation lag time was not shortened in comparison with healthy controls and was even prolonged at the end of cellulose acetate (P < 0.05) and cuprophane (P < 0.05) dialysis. HDL oxidation lag time increased (12.6% +/- 0.9%; P < 0.0001) 15 to 60 minutes after start of hemodialysis and returned to predialysis values thereafter. In patients with chronic renal failure, the lag time of HDL oxidation was significantly prolonged (13.34 minutes +/- 0.9) compared with healthy controls (10.91 +/- 2.0 minutes; P < 0.01) as well as compared with the dialysis patients at baseline (9.9 minutes +/- 1.4; P < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7702051     DOI: 10.1016/0272-6386(95)90124-8

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  5 in total

1.  Lysophosphatidic acid mediates the rapid activation of platelets and endothelial cells by mildly oxidized low density lipoprotein and accumulates in human atherosclerotic lesions.

Authors:  W Siess; K J Zangl; M Essler; M Bauer; R Brandl; C Corrinth; R Bittman; G Tigyi; M Aepfelbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

2.  Mitochondrial cholesterol transporter, StAR, inhibits human THP-1 monocyte-derived macrophage apoptosis.

Authors:  Qianming Bai; Xiaobo Li; Yanxia Ning; Fengdi Zhao; Lianhua Yin
Journal:  Lipids       Date:  2009-11-28       Impact factor: 1.880

3.  Overexpression of mitochondrial cholesterol delivery protein, StAR, decreases intracellular lipids and inflammatory factors secretion in macrophages.

Authors:  Yanxia Ning; Qianming Bai; Hong Lu; Xiaobo Li; William M Pandak; Fengdi Zhao; Sifeng Chen; Shunlin Ren; Lianhua Yin
Journal:  Atherosclerosis       Date:  2008-09-13       Impact factor: 5.162

Review 4.  Burn injury induces elevated inflammatory traffic: the role of NF-κB.

Authors:  Benu George; T V Suchithra; Nitish Bhatia
Journal:  Inflamm Res       Date:  2020-11-27       Impact factor: 4.575

5.  Analysis of differentially expressed genes in white blood cells isolated from patients with major burn injuries.

Authors:  Gongjie Tang; Tao Zhang; Xinbo Wang; Zengmei Song; Fucun Liu; Qian Zhang; Ran Huo
Journal:  Exp Ther Med       Date:  2017-08-07       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.